Get the Stockscreener App
7.05
3.03%
-0.22
After Hours:
7.05
Gyre Therapeutics Inc stock is traded at $7.05, with a volume of 96,188.
It is down -3.03% in the last 24 hours and down -4.08% over the past month.
Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
See More
Previous Close:
$7.27
Open:
$7.12
24h Volume:
96,188
Relative Volume:
0.45
Market Cap:
$660.99M
Revenue:
$106.66M
Net Income/Loss:
$15.16M
P/E Ratio:
75.40
EPS:
0.0935
Net Cash Flow:
$6.37M
1W Performance:
-4.47%
1M Performance:
-4.08%
6M Performance:
-38.75%
1Y Performance:
-51.28%
1-Day Range:
$6.93
$7.25
1-Week Range:
$6.93
$7.89
52-Week Range:
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Name
Gyre Therapeutics Inc
Sector
Industry
Phone
(619) 949-3681
Address
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Compare GYRE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
7.05 | 659.07M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-25 | Initiated | Noble Capital Markets | Outperform |
| Apr-29-21 | Resumed | Stephens | Overweight |
| Feb-10-21 | Initiated | Piper Sandler | Overweight |
| May-21-20 | Initiated | Raymond James | Outperform |
| Jan-04-19 | Initiated | Oppenheimer | Outperform |
| Feb-12-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Feb-09-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-08-17 | Initiated | B. Riley FBR, Inc. | Buy |
| Jun-12-17 | Initiated | Chardan Capital Markets | Buy |
| Jun-06-17 | Initiated | Ladenburg Thalmann | Buy |
| Jun-30-16 | Initiated | Rodman & Renshaw | Buy |
View All
Gyre Therapeutics Inc Stock (GYRE) Latest News
Price momentum metrics for Gyre Therapeutics Inc. explainedWeekly Trend Screener with Momentum Picks - Newser
Using Python tools to backtest Gyre Therapeutics Inc. strategiesFree Risk Adjusted Technical Entry Plan - Newser
How strong is Gyre Therapeutics Inc. company’s balance sheetPre Market Entry Points To Watch Now - jammulinksnews.com
Can you recover from losses in Gyre Therapeutics Inc.Conservative Equity Setup with Signal Analysis - Newser
How hedge fund analytics apply to Gyre Therapeutics Inc. stockFree Entry Zone Strategy for Consistent Profit - Newser
When is the best time to exit Gyre Therapeutics Inc.Watchlist Generator for Smart Money Signals - Newser
What makes Gyre Therapeutics Inc. stock price move sharplyReal Time Alert System for Market Moves - Newser
Combining price and volume data for Gyre Therapeutics Inc.Breakout Screener With Alert Based Timing - Newser
Will Gyre Therapeutics Inc. stock benefit from AI tech trendsWatchlist for Low Risk High Return Stocks Updated - metal.it
How to use a screener to detect Gyre Therapeutics Inc. breakoutsFree Swing Trading Entry Point Signals - Newser
Will Gyre Therapeutics Inc. Recover After Recent DeclineReal Trader Watchlist of Hot Stocks Released - metal.it
Why is Gyre Therapeutics Inc. stock attracting strong analyst attentionChart Pattern Forecasts For Consistent Profits - jammulinksnews.com
What institutional investors are buying Gyre Therapeutics Inc. stockReal Time Strategy For Consistent Profits - jammulinksnews.com
Gyre Therapeutics Inc. stock trend outlook and recovery pathHistorical Market Behavior and Trend Summary - Newser
How volatile is Gyre Therapeutics Inc. stock compared to the marketInvest smarter with expert trading signals - jammulinksnews.com
What is Gyre Therapeutics Inc. company’s growth strategyFree Stock Market Return Analysis - jammulinksnews.com
Should I hold or sell Gyre Therapeutics Inc. stock in 2025Capitalize on proven investment strategies - jammulinksnews.com
What makes Gyre Therapeutics Inc. stock price move sharply Short-Term Trade Setup with Forecast Insight - Newser
Price momentum metrics for Gyre Therapeutics Inc. explained Equity Portfolio Outlook and Performance Summary - Newser
What are the technical indicators suggesting about Gyre Therapeutics Inc.Maximize your portfolio’s growth with expert tips - jammulinksnews.com
Is Gyre Therapeutics Inc. stock overvalued or undervaluedUnlock daily market insights for better trades - jammulinksnews.com
What are Gyre Therapeutics Inc. company’s key revenue driversUnlock powerful market trend analysis - jammulinksnews.com
What catalysts could drive Gyre Therapeutics Inc. stock higher in 2025Free Stock Market Beginners Guide - jammulinksnews.com
Gyre Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingHigh Win Rate Stock Ideas - Newser
Why MDGL stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser
What are the latest earnings results for Gyre Therapeutics Inc.Consistently outstanding ROI - jammulinksnews.com
What drives Gyre Therapeutics Inc. stock priceExtraordinary performance - PrintWeekIndia
Is Gyre Therapeutics Inc. stock a growth or value playRapidly expanding wealth - jammulinksnews.com
What analysts say about Gyre Therapeutics Inc. stockFastest return on investment - PrintWeekIndia
Why Gyre Therapeutics Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
Should Gyre Therapeutics, Inc. (NASDAQ:GYRE) Focus On Improving This Fundamental Metric? - 富途牛牛
Is Gyre Therapeutics Inc. a good long term investmentMarket-crushing profits - jammulinksnews.com
Gyre Therapeutics Inc Stock (GYRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):